CII (CII) Stock Price & Analysis
CII (CII) rose 0.00% to USD 24.48 as of July 25, 2026 at 03:10 UTC, according to Nexqual real-time market data.
CII last closed at USD 24.48; the session ranged USD 24.2–24.57 on volume of 71,026 shares. Market capitalization is —, with a 52-week range of USD 20.43–26.17 (NYQ). Source: Nexqual, July 25, 2026 at 03:10 UTC.
Key Statistics (as of July 25, 2026 at 03:10 UTC)
| Price | USD 24.48 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 24.48 |
| Open | USD 24.48 |
| Day Range | USD 24.2 – 24.57 |
| 52-Week Range | USD 20.43 – 26.17 |
| Volume | 71,026 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (CII)
Nexqual's technical model rates CII "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 03:10 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 42.76 (neutral) |
| vs SMA50 | Below (USD 25) |
| MACD | -0.11 (negative) |
Earnings (CII)
Source: Nexqual, July 25, 2026 at 03:10 UTC.
Financials & Fundamentals (CII)
| Total Revenue | $8.18M |
|---|---|
| Revenue Growth (YoY) | -4.50% |
| Gross Margin | +100.00% |
| Operating Margin | +4.70% |
| Profit Margin | +2542.45% |
| ROE | +22.76% |
| Debt / Equity | 0 |
| Current Ratio | 0.01 |
| Total Cash | $664 |
| Total Debt | $14,001 |
| Free Cash Flow | $80.46M |
Source: Nexqual, July 25, 2026 at 03:10 UTC.
Financial Health Score (CII)
Nexqual rates CII's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 03:10 UTC.
| Growth | Weak — Revenue -5% YoY (latest Q), declining |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Solid — $664 cash, no debt |
| Cash Flow | Strong — FCF $80M, 984% margin |
| Efficiency | Strong — ROE 23%, ROA -0.0% |
Ownership (CII)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +21.77% |
| Shares Outstanding | 40.98M |
| Short % of Float | +1.56% |
Source: Nexqual, July 25, 2026 at 03:10 UTC.
Major Backers & Investors (CII)
Notable institutional backers of CII include Raymond James Financial, Inc., Morgan Stanley, Wells Fargo & Company, according to Nexqual as of July 25, 2026 at 03:10 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Raymond James Financial, Inc. | 2.53% |
| Morgan Stanley | 1.78% |
| Wells Fargo & Company | 1.67% |
| Invesco | 1.59% |
| LPL Financial LLC | 1.31% |
| Osaic Holdings Inc. | 1.18% |
| Bank of America Corporation | 1.13% |
| Advisors Asset Management, Inc. | 1.07% |
Source: Nexqual, July 25, 2026 at 03:10 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BDJ | Blackrock Enhanced Equity Divid | USD 9.59 | ▼ 1.13% |
| BOE | Blackrock Enhanced Global Divid | USD 11.91 | ▼ 0.5% |
| BGY | Blackrock Enhanced Internationa | USD 5.65 | ▼ 1.05% |
| ETY | Eaton Vance Tax-Managed Diversi | USD 14.24 | ▼ 0.84% |
| BME | Blackrock Health Sciences Trust | USD 42.85 | ▲ 1.16% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:10 UTC. This page is informational and not investment advice.